Page last updated: 2024-10-22

albuterol and Intestinal Obstruction

albuterol has been researched along with Intestinal Obstruction in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Intestinal Obstruction: Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nellgård, P1
Bojö, L1
Jönsson, A1
Cassuto, J1

Other Studies

1 other study available for albuterol and Intestinal Obstruction

ArticleYear
Influence of adrenoceptor agonists and antagonists on fluid secretion in small bowel obstruction.
    European journal of gastroenterology & hepatology, 1995, Volume: 7, Issue:11

    Topics: Adrenergic Agonists; Adrenergic Antagonists; Albuterol; Analysis of Variance; Animals; Body Water; C

1995